Lung cancer is the leading cause of cancer-related deaths worldwide, but early detection through screening can significantly reduce its impact. Low-dose CT (LDCT) scans are a powerful tool for identifying lung cancer in its earliest, most treatable stages. Research shows that LDCT screening reduces lung cancer mortality by up to 20% in high-risk populations, such as current or former smokers. Catching lung cancer early not only improves survival rates but also minimizes the need for invasive treatments, ultimately improving quality of life for patients.

Despite these benefits, lung cancer disproportionately affects individuals from lower socioeconomic statuses (SES) and minority groups, often due to higher rates of smoking, limited access to healthcare, and environmental exposures like air pollution. These populations are also less likely to undergo screening, contributing to disparities in outcomes. Addressing this gap requires targeted efforts to improve awareness, accessibility, and outreach, ensuring that all individuals, regardless of background, can benefit from early detection.

The process of lung cancer screening is straightforward but highly effective. Eligible individuals—typically adults aged 50 to 80 with a history of heavy smoking—undergo a quick, low-dose CT scan that creates detailed images of the lungs. This non-invasive procedure allows doctors to identify small abnormalities that might not be detectable through other means. For those who meet the criteria, regular screening offers the best chance to catch lung cancer early, often before symptoms develop.

Pluto Health takes this a step further by using advanced tools to identify patients who qualify for LDCT screening. By analyzing a patient’s medical history, smoking status, and other risk factors, Pluto Health’s platform ensures that high-risk individuals are flagged for preventive care. Additionally, the platform integrates other aspects of preventive health, helping patients stay on top of essential screenings and follow-ups. By harnessing technology, Pluto Health bridges gaps in care and brings life-saving tools like LDCT screening to those who need them most, transforming early detection into a reality for underserved populations.